Visipaque Interactions
There are 147 drugs known to interact with Visipaque (iodixanol), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 85 are major, and 62 are moderate.
- View all 147 medications that may interact with Visipaque
- View Visipaque alcohol/food interactions (1)
- View Visipaque disease interactions (7)
Most frequently checked interactions
View interaction reports for Visipaque (iodixanol) and the medicines listed below.
- Adalat (nifedipine)
- allopurinol
- amlodipine
- atenolol
- Avandamet (metformin / rosiglitazone)
- barium sulfate
- Calan (verapamil)
- Cardizem (diltiazem)
- Cartia XT (diltiazem)
- Dilacor XR (diltiazem)
- Diltia XT (diltiazem)
- diltiazem
- Fortamet (metformin)
- gadobenate dimeglumine
- glipizide / metformin
- Glucophage (metformin)
- Glucovance (glyburide / metformin)
- Glumetza (metformin)
- glyburide / metformin
- Inderal (propranolol)
- InnoPran XL (propranolol)
- Isoptin (verapamil)
- Isovue-300 (iopamidol)
- Lopressor (metoprolol)
- losartan
- MD-Gastroview (diatrizoate)
- metformin
- metoprolol
- Nifediac CC (nifedipine)
- Nifedical XL (nifedipine)
Visipaque alcohol/food interactions
There is 1 alcohol/food interaction with Visipaque (iodixanol).
Visipaque disease interactions
There are 7 disease interactions with Visipaque (iodixanol) which include:
- hyperthyroidism
- pheochromocytoma
- sickle cell disease
- multiple myeloma
- myasthenia gravis
- renal disease
- allergies
More about Visipaque (iodixanol)
- Visipaque consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.